FdaApplication
ANDA 208252
Identifiers
- fda_app_no: ANDA208252
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 2019-03-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AMBRISENTAN | AMBRISENTAN | 10MG | TABLET;ORAL |
| AMBRISENTAN | AMBRISENTAN | 5MG | TABLET;ORAL |
2 products